| Vol. 15.36 – 22 September, 2023 |
| |
|
|
| The authors showed a new link between the stress-associated catecholamines and the progression of T cell exhaustion through the β1-adrenergic receptor ADRB1. [Nature] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators showed that proliferating effector CD8+ T cells reductively carboxylated glutamine through the mitochondrial enzyme isocitrate dehydrogenase 2. [Nature] |
|
|
|
| Scientists exploited tumor microenvironment-responsive nanoparticles that simultaneously harnessed STING and Toll-like receptor 4 (TLR4) to augment STING activation via TLR4-mediated nuclear factor-kappa B signaling pathway stimulation. [Advanced Materials] |
|
|
|
| The authors identified a stem cell-like CD7+ monocyte subpopulation accumulating in the bone marrow of mice and humans that experienced dieting-induced weight loss. [Cell Metabolism] |
|
|
|
| Researchers identified 10 subsets of human tumor-infiltrating-Treg, most of which had high concordance with murine tumor-infiltrating-Treg subsets. [Science Immunology] |
|
|
|
| Scientists identified a distinct subset of T cell factor-1 (TCF1)+ CD8+ T cells in mouse allogeneic and xenogeneic transplant models of acute graft-versus-host disease. [Nature Communications] |
|
|
|
| The prophylactic use of a protein arginine methyltransferase 1 (PRMT1) inhibitor significantly prevented chronic graft-versus-host disease in mice by reducing the percentage of Th17 cells, germinal center B cells, and plasma cells. [Molecular Therapy] |
|
|
|
| Investigators established that CD4+ T cells responded to intermittent T cell receptor (TCR) stimulation more efficiently than their CD8+ T cells counterparts and provided evidence that distinct sequences of TCR stimulation encoded different cytokine programs. [Proceedings Of The National Academy Of Sciences Of The United States Of America] |
|
|
|
| Using cell-specific IL-15-deficient mice, researchers showed that hematopoietic cells, but not stromal cells, supported natural killer (NK) cell development in the bone marrow through IL-15. [Cell Reports] |
|
|
|
|
| Scientists review the studies that support or challenge a widely-held view of immune aging, and discuss the implications for vaccination strategies. [Seminars In Immunology] |
|
|
|
|
| Penn Medicine’s Carl June has been named a winner of the 2024 Breakthrough Prize in Life Sciences for the development of CAR T cell immunotherapy, a revolutionary cancer treatment approach in which each patient’s T cells are modified to target and kill their cancer cells. [Penn Today] |
|
|
|
| The US biomedical agency tweaked its new policy after an outcry from researchers, but will forge ahead. [Nature News] |
|
|
|
|
| October 17 – 19, 2023 London, England, United Kingdom |
|
|
|
|
|
| Stanford University – Stanford, California, United States |
|
|
|
| Georgetown University – Washington D.C., United States |
|
|
|
| McGill University – Montreal, Quebec, Canada |
|
|
|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) – Bethesda, Maryland, United States |
|
|
|
| Sanders Tri-Institutional Therapeutics Discovery Institute – New York, New York, United States |
|
|
|
|